Trial Profile
Atorvastatin compared with simvastatin in the prevention of CHD morbidity and mortality in patients with CHD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Simvastatin
- Indications Coronary disorders; Heart failure; Myocardial infarction
- Focus Therapeutic Use
- Acronyms IDEAL
- Sponsors Pfizer
- 26 Jun 2021 Results of pooled post-hoc analysis of two studies (IDEAL, NCT00159835 and TNT, NCT00327691) were presented at The International Liver Congress 2021.
- 04 Nov 2016 Results of post-hoc analysis published in the American Journal of Cardiology.
- 05 Apr 2011 Results of a pharmacogenomic analysis presented in combination with results from the TNT study at the 60th Annual Scientific Session of the American College of Cardiology.